pillbase.ru

VABYSMO

Active substance: faricimab

INJECTION, SOLUTION · FARICIMAB 6 mg/.05mL

United StatesActive

Marketing holder: Genentech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Вабисмо®
    раствор для внутриглазного введения, 120 мг/мл, 0.24 мл (original in Russian, GRLS)
    ЛП-№(001664)-(РГ-RU)
    Ф. Хоффманн-Ля Рош Лтд.
EU 1
  • Vabysmo
    Faricimab
    EMEA/H/C/005642
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-4174-7f9d-b57e-19cf287a1a1f;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6ac3-7ac6-9c6e-3522ea3a42e5;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50242-096
Registration status
Active
Dispensing
Prescription only
Route
INTRAVITREAL
Sources
  • product · openFDA NDC · 50242-096 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50242-096 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50242-096 · Verified 2026-10-09 · open in source